BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020
28 Abril 2020 - 7:00AM
BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly
growing specialty pharmaceutical company dedicated to patients
living with serious and complex chronic conditions, today announced
that it will report its first quarter 2020 financial results after
the close of the U.S. financial markets on Thursday, May 7,
2020. The Company will host a conference call and webcast at 4:30
PM Eastern Time to discuss the results and provide an update
on business operations.
Conference Call Dial-In & Webcast
Information:
Date: |
Thursday, May 7, 2020 |
Time: |
4:30 PM Eastern Time |
Domestic: |
800-289-0571 |
International: |
720-543-0206 |
Conference ID: |
6176462 |
Webcast: |
http://public.viavid.com/index.php?id=139300 |
About BioDelivery Sciences
International, Inc.BioDelivery Sciences International,
Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical
company dedicated to patients living with chronic conditions. BDSI
has built a portfolio of products that includes utilizing its novel
and proprietary BioErodible MucoAdhesive (BEMA®) technology to
develop and commercialize, either on its own or in partnership with
third parties, new applications of proven therapies aimed at
addressing important unmet medical needs. BDSI's marketed products
address serious and debilitating conditions, including chronic
pain, opioid dependence, and opioid-induced constipation.
© 2020 BioDelivery Sciences International,
Inc. All rights reserved.
Contact:Tirth T. PatelDirector
of Investor Relationstpatel@bdsi.com(919) 582-0294
BioDelivery Sciences (NASDAQ:BDSI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
BioDelivery Sciences (NASDAQ:BDSI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about BioDelivery Sciences International Inc (NASDAQ): 0 recent articles
Más de Artículos de Noticias